DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma-A phase 3 randomized trial.

Patrick M. Forde; Anna K. Nowak; Peey-Sei Kok; Chris Brown; Zhuoxin Sun; Valsamo Anagnostou; Kenneth John O'Byrne; Sonia Yip; Alistair Cook; Willem Joost Lesterhuis; Brett Gordon Maxwell Hughes; Nick Pavlakis; Julie R. Brahmer; Hedy L. Kindler; Anne S. Tsao; Marjorie Glass Zauderer; Suresh S. Ramalingam; Martin R. Stockler

DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma-A phase 3 randomized trial.

Patrick M. Forde, Anna K. Nowak, Peey-Sei Kok, Chris Brown, Zhuoxin Sun, Valsamo Anagnostou, Kenneth John O'Byrne, Sonia Yip, Alistair Cook, Willem Joost Lesterhuis, Brett Gordon Maxwell Hughes, Nick Pavlakis, Julie R. Brahmer, Hedy L. Kindler, Anne S. Tsao, Marjorie Glass Zauderer, Suresh S. Ramalingam, Martin R. Stockler

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	40
Issue number	16
Publication status	Published - 1 Jun 2022

Cite this

Forde, P. M., Nowak, A. K., Kok, P-S., Brown, C., Sun, Z., Anagnostou, V., O'Byrne, K. J., Yip, S., Cook, A., Lesterhuis, W. J., Hughes, B. G. M., Pavlakis, N., Brahmer, J. R., Kindler, H. L., Tsao, A. S., Zauderer, M. G., Ramalingam, S. S., & Stockler, M. R. (2022). DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma-A phase 3 randomized trial. Journal of Clinical Oncology, 40(16).

@article{19c4f46dcb9548ffa5a3a70cff00fb79,

title = "DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma-A phase 3 randomized trial.",

author = "Forde, {Patrick M.} and Nowak, {Anna K.} and Peey-Sei Kok and Chris Brown and Zhuoxin Sun and Valsamo Anagnostou and O'Byrne, {Kenneth John} and Sonia Yip and Alistair Cook and Lesterhuis, {Willem Joost} and Hughes, {Brett Gordon Maxwell} and Nick Pavlakis and Brahmer, {Julie R.} and Kindler, {Hedy L.} and Tsao, {Anne S.} and Zauderer, {Marjorie Glass} and Ramalingam, {Suresh S.} and Stockler, {Martin R.}",

year = "2022",

month = jun,

day = "1",

language = "English",

volume = "40",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "16",

}

Forde, PM, Nowak, AK, Kok, P-S, Brown, C, Sun, Z, Anagnostou, V, O'Byrne, KJ, Yip, S, Cook, A , Lesterhuis, WJ, Hughes, BGM, Pavlakis, N, Brahmer, JR, Kindler, HL, Tsao, AS, Zauderer, MG, Ramalingam, SS & Stockler, MR 2022, 'DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma-A phase 3 randomized trial.', Journal of Clinical Oncology, vol. 40, no. 16.

TY - JOUR

T1 - DREAM3R

T2 - Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma-A phase 3 randomized trial.

AU - Forde, Patrick M.

AU - Nowak, Anna K.

AU - Kok, Peey-Sei

AU - Brown, Chris

AU - Sun, Zhuoxin

AU - Anagnostou, Valsamo

AU - O'Byrne, Kenneth John

AU - Yip, Sonia

AU - Cook, Alistair

AU - Lesterhuis, Willem Joost

AU - Hughes, Brett Gordon Maxwell

AU - Pavlakis, Nick

AU - Brahmer, Julie R.

AU - Kindler, Hedy L.

AU - Tsao, Anne S.

AU - Zauderer, Marjorie Glass

AU - Ramalingam, Suresh S.

AU - Stockler, Martin R.

PY - 2022/6/1

Y1 - 2022/6/1

M3 - Abstract/Meeting Abstract

SN - 0732-183X

VL - 40

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

IS - 16

ER -